TickerFacts.

Incyte Corp (INCY): Total Assets

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$6.96B
As of 2025-12-31
$7.34B
As of 2026-03-31
+6.0%
3-year compound annual growth
+14.3%
5-year compound annual growth
+21.3%
10-year compound annual growth
2010-12-31: $489.58M2011-12-31: $328.96M2012-12-31: $330.42M2013-12-31: $629.57M2014-12-31: $796.48M2015-12-31: $1.01B2016-12-31: $1.64B2017-12-31: $2.30B2018-12-31: $2.65B2019-12-31: $3.43B2020-12-31: $3.56B2021-12-31: $4.93B2022-12-31: $5.84B2023-12-31: $6.78B2024-12-31: $5.44B2025-12-31: $6.96B$6.96B
2010-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$6.96B+27.8%2026-02-10, Balance as of period end
2024-12-31$5.44B-19.7%2026-02-10, Balance as of period end
2023-12-31$6.78B+16.1%2025-02-10, Balance as of period end
2022-12-31$5.84B+18.4%2024-02-13, Balance as of period end
2021-12-31$4.93B+38.5%2023-02-07, Balance as of period end
2020-12-31$3.56B+3.9%2022-02-08, Balance as of period end
2019-12-31$3.43B+29.5%2021-02-09, Balance as of period end
2018-12-31$2.65B+14.9%2020-02-13, Balance as of period end
2017-12-31$2.30B+40.5%2019-02-14, Balance as of period end
2016-12-31$1.64B+62.6%2018-02-15, Balance as of period end
2015-12-31$1.01B+26.5%2017-02-14, Balance as of period end
2014-12-31$796.48Mn/c2016-02-12, Balance as of period end
2013-12-31$629.57M+90.5%2015-02-17, Balance as of period end
2012-12-31$330.42M+0.4%2014-02-21, Balance as of period end
2011-12-31$328.96M-32.8%2013-02-21, Balance as of period end
2010-12-31$489.58Mn/a2012-02-22, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Incyte Corp (INCY)2025-12-31$6.96B+27.8%
Charles River Laboratories International, Inc. (CRL)2025-12-27$7.14B-5.2%
Icon PLC (ICLR)2025-12-31$16.27B-2.2%
Medpace Holdings, Inc. (MEDP)2025-12-31$1.98B-6.0%
Iqvia Holdings Inc. (IQV)2025-12-31$29.94B+11.3%
NRC Health (NRC)2025-12-31$134.88M+1.8%
MaxCyte, Inc. (MXCT)2025-12-31$202.51M-15.4%
OmniAb, Inc. (OABI)2025-12-31$300.91M-7.6%
Foxo Technologies Inc. (FOXO)2025-12-31$44.58M+6.9%

Compare INCY, CRL, ICLR, MEDP side by side · Screen every company in Services-Commercial Physical & Biological Research ↗